Pharmaceutical Executive-05-01-2010

One Pill Makes You Better?

Timely and accessible information can help break through the firewall of regulation.

The Orphan Drug Act of 1983 has been a roaring success. So why is everybody trying to mess with it?

The new world of mobile applications is sparking creative platforms for reaching consumers and physicians.

Cash-rich Big Pharmas are hedging their bets to cover both segments under the rubric of "diversification." If it sticks to the wall, then buy it.

The three-way race for control of Parliament leaves the future of the British pharmaceutical industry in the balance.

Marketers must focus on getting busy women the help they need in making critical decisions about their healthcare.

Under the new healthcare regime, pharma will ante up fees and rebates in return for expanded sales and safeguards.